Article
Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation.
Blood - 1 Dec 1998
Tezcan I, Xu W, Gurgey A, Tuncer M, Cetin M, Oner C, Yetgin S, Ersoy F, Aizencang G, Astrin K H, Desnick R J
Abstract excerpt
The long-term biochemical and clinical effectiveness of allogenic bone marrow transplantation (BMT) was shown in a severely affected, transfusion-dependent 18-month-old female with congenital erythropoietic porphyria (CEP), an autosomal recessive inborn error of heme biosynthesis resulting from mutations in the uroporphyrinogen III synthase (URO-synthase) gene. Three years post-BMT, the recipient had normal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.